Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 3;96(44):e8486. doi: 10.1097/MD.0000000000008486

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

PMC Copyright notice

Cumulative overall survivals and progression free survivals after propensity score weighting by treatment type The cumulative OS rates were significantly higher in the SR (P < .001) and RFA (P = .027) group than in the TACE group, respectively (A). The cumulative PFS rates were significantly higher in the SR (P < .001) and RFA (P < .001) group than in the TACE group, respectively (B). However, the cumulative OS and PFS rates of SR group showed no significant difference compared with those of RFA group (P = .116 and P = .252, respectively) (A and B). OS = overall survival, PFS = progression-free survival, RFA = radio frequency ablation, SR = surgical resection, TACE = transarterial chemoembolization.